StockDriftsStockDriftsMAIA Biotechnology, Inc. has 3 SEC filings in the last 90 days, latest: CEO Vlad Vitoc buys 73,000 shares for $100,010 (4, September 15, 2026). Each filing below is summarised from the document itself and links straight to the original on SEC EDGAR.
Of the 3 filings tracked here, 3 report insider buys. See only MAIA Form 4 filings.
MAIA Biotechnology CEO Vlad Vitoc purchased 73,000 common shares at $1.37 in an open-market transaction worth $100,010, not under a 10b5-1 plan.
Director Ramiro Guerrero bought 37,595 shares of common stock for $49,516.37.
Director Ramiro Guerrero bought 133,790 shares of common stock for a total of $184,103.30.